Rebecca Todd
Private Equity Investor bei Longwall Venture Partners LLP
Profil
Rebecca Todd is currently an Investment Director at Longwall Venture Partners LLP.
She previously worked as a Director at Sirigen Group Ltd., Veryan Medical Ltd., and BioCity Group Ltd.
(2019-2021).
She also served as a Non-Executive Director at Molecular Vision Ltd.
and Abingdon Health Plc, and as a Director at Ieso Digital Health Ltd.
Additionally, she worked as an Investment Manager at Oxford Capital Partners LLP.
Dr. Todd holds an MBA from the University of Oxford, an undergraduate degree from the University of York, and a doctorate from the University of Nottingham.
Aktive Positionen von Rebecca Todd
Unternehmen | Position | Beginn |
---|---|---|
Longwall Venture Partners LLP
Longwall Venture Partners LLP Investment ManagersFinance Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom. | Private Equity Investor | 01.11.2017 |
Ehemalige bekannte Positionen von Rebecca Todd
Unternehmen | Position | Ende |
---|---|---|
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 30.11.2021 |
Oxford Capital Partners LLP
Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom. | Private Equity Investor | 01.01.2011 |
Ieso Digital Health Ltd.
Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
ABINGDON HEALTH PLC | Direktor/Vorstandsmitglied | - |
Molecular Vision Ltd.
Molecular Vision Ltd. Medical SpecialtiesHealth Technology Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Rebecca Todd
University of Oxford | Masters Business Admin |
The University of York | Undergraduate Degree |
The University of Nottingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ABINGDON HEALTH PLC | Health Technology |
Private Unternehmen | 7 |
---|---|
Oxford Capital Partners LLP
Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom. | Finance |
Sirigen Group Ltd.
Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Harnessing the power of novel light-harvesting polymeric materials, Sirigen's amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. The company's versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications. Its platform agnostic, enabling technology represents a quantum leap in detection capabilities, amplifying the sensitivity of a wide range of existing instrumentation and detection platforms by up to 100 fold. The company's technology is applicable to a diverse cross section of the biomedical industry including the $6billion drug discovery industry which can use it to test the efficacy of new drugs, the $12billion life sciences industry which can use Sirigen to develop new detection platforms, and the $35billion diagnostics industry, which can work with the company to optimise existing diagnostic techniques and to develop the next generation of diagnostic tools. Indeed the potential to deliver real time testing on miniaturised monitoring devices is close to reality. | Process Industries |
Molecular Vision Ltd.
Molecular Vision Ltd. Medical SpecialtiesHealth Technology Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom. | Health Technology |
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Finance |
Ieso Digital Health Ltd.
Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Longwall Venture Partners LLP
Longwall Venture Partners LLP Investment ManagersFinance Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom. | Finance |
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Health Technology |